Table 1 Correlation between the TRPV1 expression and clinicopathological characteristics in 100 patients with GC
From: The role of TRPV1 ion channels in the suppression of gastric cancer development
Characteristic | No. Patients (n=<100) | TRPV1 Expression | Chi-square | P-value | |
|---|---|---|---|---|---|
Low No. (%) | High No. (%) | ||||
Age | |||||
 <60 years | 32 | 15 (46.9%) | 17 (53.1%) | 0.508 | 0.476 |
 ≥60 years | 66 | 36 (54.5%) | 30 (45.5%) | ||
Gender | |||||
 Male | 64 | 31 (48.4%) | 33 (51.6%) | 1.486 | 0.223 |
 Female | 36 | 22 (61.1%) | 14 (38.9%) | ||
Tumor size | |||||
 <5 cm | 39 | 11 (28.2%) | 28 (71.8%) | 14.746 | <0.001* |
 ≥5 cm | 59 | 40 (67.8%) | 19 (32.2%) | ||
Histological grade | |||||
 G1/2 | 22 | 6 (27.3%) | 16 (72.7%) | 7.494 | 0.006* |
 G3/4 | 78 | 47 (60.3%) | 31 (39.7%) | ||
Lymphatic metastasis | |||||
 Negative | 27 | 7 (25.9%)) | 20 (74.1%) | 10.884 | 0.001* |
 Positive | 73 | 46 (63.0%) | 27 (37.0%) | ||
Clinical stage | |||||
 I/II | 42 | 11 (26.2%) | 31 (73.8%) | 20.288 | <0.001* |
 III/IV | 57 | 41 (71.9%) | 16 (28.1%) | ||